These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 911347)

  • 1. In vitro hydroxylation of diphenylhydantoin and its inhibition by other commonly used anticonvulsant drugs.
    Patsalos PN; Lascelles PT
    Biochem Pharmacol; 1977 Oct; 26(20):1929-33. PubMed ID: 911347
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of in vitro diphenylhydantoin hydroxylation by different anticonvulsant drug combinations: a kinetic analysis.
    Patsalos PN; Lascelles PT
    Gen Pharmacol; 1981; 12(1):51-5. PubMed ID: 7250668
    [No Abstract]   [Full Text] [Related]  

  • 3. Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1984; 12(5):560-4. PubMed ID: 6149905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
    Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphenylhydantoin substrate induced difference spectra: inhibition by other anticonvulsant drugs.
    Patsalos PN; Lascelles PT
    Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):31-43. PubMed ID: 6102406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Felbamate in vitro metabolism by rat liver microsomes.
    Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1135-8. PubMed ID: 1687021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of d-propoxyphene and diphenylhydantoin in rat liver microsomal preparation.
    Verebey K
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):21-9. PubMed ID: 663405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
    Butler TC; Dudley KH; Mitchell GN; Johnson D
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.
    Doecke CJ; Veronese ME; Pond SM; Miners JO; Birkett DJ; Sansom LN; McManus ME
    Br J Clin Pharmacol; 1991 Feb; 31(2):125-30. PubMed ID: 2049228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk prediction of drug-drug interaction potential of phenytoin and miconazole topical formulations.
    Li W; Wang Z; Wang X; Cao X; Bi C; Jiang L; Cui S; Liu Y
    Chem Biol Interact; 2021 Jul; 343():109498. PubMed ID: 33961833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of microsomal phenytoin metabolism by nafimidone and related imidazoles. Potency and structural considerations.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1985; 13(4):430-7. PubMed ID: 2863106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of phenytoin to reactive metabolites in rat liver microsomes.
    Billings RE; Milton SG
    Adv Exp Med Biol; 1986; 197():931-9. PubMed ID: 3020938
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of p-hydroxyphenytoin in microsomal reactions by high-performance liquid chromatography with electrochemical detection.
    Kapetanovic IM; Kupferberg HJ
    J Chromatogr; 1984 Oct; 310(2):418-23. PubMed ID: 6511859
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism and anticonvulsant activity of deuterated N-demethyldiazepam.
    Marcucci F; Mussini E; Martelli P; Guaitani A; Garattini S
    J Pharm Sci; 1973 Nov; 62(11):1900-2. PubMed ID: 4148451
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins.
    Pantarotto C; Arboix M; Sezzano P; Abbruzzi R
    Biochem Pharmacol; 1982 Apr; 31(8):1501-7. PubMed ID: 7092941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenylhydantoin metabolism. A prospective review.
    Glazko AJ
    Drug Metab Dispos; 1973; 1(5):711-4. PubMed ID: 4149711
    [No Abstract]   [Full Text] [Related]  

  • 17. Diphenylhydantoin metabolism by rat liver microsomes and some of the effects of drug or chemical pretreatment on diphenylhydantoin metabolism by rat liver microsomal preparations.
    Kutt H; Fouts JR
    J Pharmacol Exp Ther; 1971 Jan; 176(1):11-26. PubMed ID: 5569630
    [No Abstract]   [Full Text] [Related]  

  • 18. Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats.
    Konishi H; Yoshimoto T; Morita K; Minouchi T; Sato T; Yamaji A
    J Pharm Pharmacol; 2003 Jan; 55(1):143-9. PubMed ID: 12625878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CYP2C-mediated stereoselective phenytoin hydroxylation in Japanese: difference in chiral preference of CYP2C9 and CYP2C19.
    Yasumori T; Chen LS; Li QH; Ueda M; Tsuzuki T; Goldstein JA; Kato R; Yamazoe Y
    Biochem Pharmacol; 1999 Jun; 57(11):1297-303. PubMed ID: 10230773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of diphenylhydantoin by rat liver microsomes. I. characteristics of the reaction.
    Kutt H; Verebely K
    Biochem Pharmacol; 1970 Mar; 19(3):675-86. PubMed ID: 4396252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.